Kantonsspital St.Gallen

ALXN1210-ALS-308: An Efficacy and Safety Study of Ravulizumab in ALS Patients

Christoph Neuwirth, Markus Weber & Nathalie Braun

abstract The purpose of the study is to assess the efficacy and safety of ravulizumab for the treatment of adult participants with ALS.
type of project clinical studies
status aborted
start of project 2020
end of project 2021
responsible person Neuwirth,, Christoph